2018 - 2021 Investigation about LAMP-2 which could be a noble therapeutic target against choriocarcinoma
Papers (129):
Mayu Shibata, Kosuke Yoshida, Akira Yokoi, Hironori Suzuki, Yusuke Yamamoto, Masami Kitagawa, Eri Asano-Inami, Yuko Yasui, Yuki Nishiko, Masato Yoshihara, et al. Elucidation of the role of XBP1 in the progression of complete hydatidiform mole to invasive mole through RNA-seq. Gynecologic oncology. 2024. 190. 189-199
Yukari Oda, Kaoru Niimi, Kosuke Yoshida, Satoshi Tamauchi, Akira Yokoi, Yuko Yasui, Yuki Nishiko, Mayu Shibata, Yusuke Shimizu, Masato Yoshihara, et al. Establishment and characterization of a non-gestational choriocarcinoma patient-derived xenograft model. BMC cancer. 2023. 23. 1. 1103-1103
Nishino K, Inthaphatha S, Yamamoto E. Increased number of live births by migrant mothers shows areal inequality in Japan: A descriptive study. SSM - population health. 2023. 23. 101447
Niimi K, Yamamoto E, Oda Y, Nishiko Y, Shibata M, Nishino K, Kajiyama H. A case of complete remission of intractable gestational choriocarcinoma with subsequent chemotherapy after pembrolizumab. Taiwanese journal of obstetrics & gynecology. 2023. 62. 5. 745-748
Frozanfar Muhammad Kamel, Hamajima Nobuyuki, Fayaz Said Hafizullah, Rahimzad Abdullah Darman, Stanekzai Hedayatullah, Inthaphatha Souphalak, Nishino Kimihiro, Yamamoto Eiko. Factors associated with pentavalent vaccine coverage among 12-23-month-old children in Afghanistan: A cross-sectional study. PLOS ONE. 2023. 18. 8. e0289744